The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique

We examined the impact of chemoprophylaxis on the cellular and humoral immune responses to polypeptides of the asexual Plasmodium falciparum blood stage antigens, the glutamate rich protein GLURP and Pf155/RESA, both of which in previous field studies have been identified as potentially protective a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta tropica 1994-09, Vol.57 (4), p.265-277
Hauptverfasser: Hogh, Birthe, Thompson, Ricardo, Lobo, Vitoria, Dgedge, Martinho, Dziegiel, Morten, Borre, Martin, Gottschau, Adam, Streat, Elisabeth, Schapira, Allan, Barreto, Jorge
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 277
container_issue 4
container_start_page 265
container_title Acta tropica
container_volume 57
creator Hogh, Birthe
Thompson, Ricardo
Lobo, Vitoria
Dgedge, Martinho
Dziegiel, Morten
Borre, Martin
Gottschau, Adam
Streat, Elisabeth
Schapira, Allan
Barreto, Jorge
description We examined the impact of chemoprophylaxis on the cellular and humoral immune responses to polypeptides of the asexual Plasmodium falciparum blood stage antigens, the glutamate rich protein GLURP and Pf155/RESA, both of which in previous field studies have been identified as potentially protective antigens. The study was carried out in the Escola Primária de Lingamo, a primary school in a suburban area of Maputo, Mozambique. A cohort of 392 schoolchildren (aged 7–12 years) was randomly allocated to two equal groups, one receiving chemoprophylaxis with dapsone/pyrimethamine (Maloprim), the other receiving placebo every week from December 1989 to November 1990. The groups were then followed until November 1991 without chemoprophylaxis. Cellular responses to immunodominant epitopes from Pf155/RESA and GLURP, and to non malaria antigens C. albicans and PPD, were assessed by lymphocyte proliferation assays in vitro. Anti-GLURP and anti-Pf155/RESA antibodies were detected by enzyme-linked immunosorbent assay (ELISA) and erythrocyte membrane immunofluorescence (EMIF), and total anti- P. falciparum antibodies were measured by indirect fluorescent antibody test (IFAT). Immunological reactivities were evaluated every six months, at the end of the rainy season and at the end of the dry season, both during the period of chemoprophylaxis and during the follow-up. The antibody response rate to the GLURP was lower in the Maloprim group than in the placebo group during the intervention phase. The lymphoproliferative response rate to the malaria antigens was significantly lower at the end of the rainy season than at the end of the dry season, but the difference between the experimental group and the control group of schoolchildren was not statistically significant. These results suggest that the antibody responses to the GLURP molecule and partly to the Pf155/RESA antigen in this study population were shortlived and dependent on frequent boostering, but whether these antigens play a role in the development of natural clinical immunity remains open. In the experimental group of schoolchildren weekly chemoprophylaxis successfully reduced the parasite rate during the rainy season from 43% to 4%, and during the dry season from 18% to 0%. Chemoprophylaxis may therefore have a useful role in combination with another partially effective malaria control measure such as insecticide-impregnated bed nets or a malaria vaccine.
doi_str_mv 10.1016/0001-706X(94)90072-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76922471</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0001706X94900728</els_id><sourcerecordid>76922471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-48bf38567fd8925201aada4ba18c061e708d57b45bd34fe86ff6ae255b8f67933</originalsourceid><addsrcrecordid>eNqFUsuO1DAQjBBoGRb-ACSfEBwCduLEzgUJrXhJi-CwSNysjt2ZMfJjsJPVLp_IV-HMjPbIntxWVVe1uquqnjP6hlHWv6WUslrQ_uergb8eKBVNLR9UGyZFW_dNxx9WmzvK4-pJzr_KrxFdc1adCcloK9tN9fdqh8SGyS0YNJI4ka_g4j5ZT_QOfanifnfr4MZmEgPR6NziIBEIhuwWHxM4Yr1fApKEeR9DxkzmSL47yD4au3gygdN2D6mUkPFmKR2ji9GQPMMWi9JstxhymYJkvYvR6Z11JmEgzl7bsF0BIB6KrQWCwaC3mkBCOIwb_4Af7e8Fn1aPilXGZ6f3vPrx8cPVxef68tunLxfvL2vN2TDXXI5TK7teTEYOTddQBmCAj8Ckpj1DQaXpxMi70bR8QtlPUw_YdN0op14MbXtevTzqlt0U2zwrb_O6GAgYl6xEPzQNF-xeYtv0g2gYv5fIelFED9b8SNQp5pxwUuulIN0qRtUaCrVeXK0XVwNXh1AoWdpenPSX0aO5azqloODvjjiWtV1bTCpru-bB2IR6Viba_xv8A7eoy98</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16776993</pqid></control><display><type>article</type><title>The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hogh, Birthe ; Thompson, Ricardo ; Lobo, Vitoria ; Dgedge, Martinho ; Dziegiel, Morten ; Borre, Martin ; Gottschau, Adam ; Streat, Elisabeth ; Schapira, Allan ; Barreto, Jorge</creator><creatorcontrib>Hogh, Birthe ; Thompson, Ricardo ; Lobo, Vitoria ; Dgedge, Martinho ; Dziegiel, Morten ; Borre, Martin ; Gottschau, Adam ; Streat, Elisabeth ; Schapira, Allan ; Barreto, Jorge</creatorcontrib><description>We examined the impact of chemoprophylaxis on the cellular and humoral immune responses to polypeptides of the asexual Plasmodium falciparum blood stage antigens, the glutamate rich protein GLURP and Pf155/RESA, both of which in previous field studies have been identified as potentially protective antigens. The study was carried out in the Escola Primária de Lingamo, a primary school in a suburban area of Maputo, Mozambique. A cohort of 392 schoolchildren (aged 7–12 years) was randomly allocated to two equal groups, one receiving chemoprophylaxis with dapsone/pyrimethamine (Maloprim), the other receiving placebo every week from December 1989 to November 1990. The groups were then followed until November 1991 without chemoprophylaxis. Cellular responses to immunodominant epitopes from Pf155/RESA and GLURP, and to non malaria antigens C. albicans and PPD, were assessed by lymphocyte proliferation assays in vitro. Anti-GLURP and anti-Pf155/RESA antibodies were detected by enzyme-linked immunosorbent assay (ELISA) and erythrocyte membrane immunofluorescence (EMIF), and total anti- P. falciparum antibodies were measured by indirect fluorescent antibody test (IFAT). Immunological reactivities were evaluated every six months, at the end of the rainy season and at the end of the dry season, both during the period of chemoprophylaxis and during the follow-up. The antibody response rate to the GLURP was lower in the Maloprim group than in the placebo group during the intervention phase. The lymphoproliferative response rate to the malaria antigens was significantly lower at the end of the rainy season than at the end of the dry season, but the difference between the experimental group and the control group of schoolchildren was not statistically significant. These results suggest that the antibody responses to the GLURP molecule and partly to the Pf155/RESA antigen in this study population were shortlived and dependent on frequent boostering, but whether these antigens play a role in the development of natural clinical immunity remains open. In the experimental group of schoolchildren weekly chemoprophylaxis successfully reduced the parasite rate during the rainy season from 43% to 4%, and during the dry season from 18% to 0%. Chemoprophylaxis may therefore have a useful role in combination with another partially effective malaria control measure such as insecticide-impregnated bed nets or a malaria vaccine.</description><identifier>ISSN: 0001-706X</identifier><identifier>EISSN: 1873-6254</identifier><identifier>DOI: 10.1016/0001-706X(94)90072-8</identifier><identifier>PMID: 7810383</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Antibodies, Protozoan - biosynthesis ; Antigens, Protozoan - immunology ; Antimalarials - immunology ; Antimalarials - therapeutic use ; Cellular ; Child ; Cohort Studies ; Cross-Sectional Studies ; Dapsone ; Dapsone - immunology ; Dapsone - therapeutic use ; Drug Combinations ; Enzyme-Linked Immunosorbent Assay ; GLURP ; Humans ; Humoral immune response ; Immunity, Cellular - drug effects ; Malaria, Falciparum - epidemiology ; Malaria, Falciparum - immunology ; Malaria, Falciparum - prevention &amp; control ; Mozambique - epidemiology ; Pf155/RESA ; Plasmodium falciparum ; Plasmodium falciparum - immunology ; Protozoan Proteins - immunology ; Pyrimethamine ; Pyrimethamine - immunology ; Pyrimethamine - therapeutic use ; Seasons</subject><ispartof>Acta tropica, 1994-09, Vol.57 (4), p.265-277</ispartof><rights>1994</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-48bf38567fd8925201aada4ba18c061e708d57b45bd34fe86ff6ae255b8f67933</citedby><cites>FETCH-LOGICAL-c419t-48bf38567fd8925201aada4ba18c061e708d57b45bd34fe86ff6ae255b8f67933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0001-706X(94)90072-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7810383$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hogh, Birthe</creatorcontrib><creatorcontrib>Thompson, Ricardo</creatorcontrib><creatorcontrib>Lobo, Vitoria</creatorcontrib><creatorcontrib>Dgedge, Martinho</creatorcontrib><creatorcontrib>Dziegiel, Morten</creatorcontrib><creatorcontrib>Borre, Martin</creatorcontrib><creatorcontrib>Gottschau, Adam</creatorcontrib><creatorcontrib>Streat, Elisabeth</creatorcontrib><creatorcontrib>Schapira, Allan</creatorcontrib><creatorcontrib>Barreto, Jorge</creatorcontrib><title>The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique</title><title>Acta tropica</title><addtitle>Acta Trop</addtitle><description>We examined the impact of chemoprophylaxis on the cellular and humoral immune responses to polypeptides of the asexual Plasmodium falciparum blood stage antigens, the glutamate rich protein GLURP and Pf155/RESA, both of which in previous field studies have been identified as potentially protective antigens. The study was carried out in the Escola Primária de Lingamo, a primary school in a suburban area of Maputo, Mozambique. A cohort of 392 schoolchildren (aged 7–12 years) was randomly allocated to two equal groups, one receiving chemoprophylaxis with dapsone/pyrimethamine (Maloprim), the other receiving placebo every week from December 1989 to November 1990. The groups were then followed until November 1991 without chemoprophylaxis. Cellular responses to immunodominant epitopes from Pf155/RESA and GLURP, and to non malaria antigens C. albicans and PPD, were assessed by lymphocyte proliferation assays in vitro. Anti-GLURP and anti-Pf155/RESA antibodies were detected by enzyme-linked immunosorbent assay (ELISA) and erythrocyte membrane immunofluorescence (EMIF), and total anti- P. falciparum antibodies were measured by indirect fluorescent antibody test (IFAT). Immunological reactivities were evaluated every six months, at the end of the rainy season and at the end of the dry season, both during the period of chemoprophylaxis and during the follow-up. The antibody response rate to the GLURP was lower in the Maloprim group than in the placebo group during the intervention phase. The lymphoproliferative response rate to the malaria antigens was significantly lower at the end of the rainy season than at the end of the dry season, but the difference between the experimental group and the control group of schoolchildren was not statistically significant. These results suggest that the antibody responses to the GLURP molecule and partly to the Pf155/RESA antigen in this study population were shortlived and dependent on frequent boostering, but whether these antigens play a role in the development of natural clinical immunity remains open. In the experimental group of schoolchildren weekly chemoprophylaxis successfully reduced the parasite rate during the rainy season from 43% to 4%, and during the dry season from 18% to 0%. Chemoprophylaxis may therefore have a useful role in combination with another partially effective malaria control measure such as insecticide-impregnated bed nets or a malaria vaccine.</description><subject>Animals</subject><subject>Antibodies, Protozoan - biosynthesis</subject><subject>Antigens, Protozoan - immunology</subject><subject>Antimalarials - immunology</subject><subject>Antimalarials - therapeutic use</subject><subject>Cellular</subject><subject>Child</subject><subject>Cohort Studies</subject><subject>Cross-Sectional Studies</subject><subject>Dapsone</subject><subject>Dapsone - immunology</subject><subject>Dapsone - therapeutic use</subject><subject>Drug Combinations</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>GLURP</subject><subject>Humans</subject><subject>Humoral immune response</subject><subject>Immunity, Cellular - drug effects</subject><subject>Malaria, Falciparum - epidemiology</subject><subject>Malaria, Falciparum - immunology</subject><subject>Malaria, Falciparum - prevention &amp; control</subject><subject>Mozambique - epidemiology</subject><subject>Pf155/RESA</subject><subject>Plasmodium falciparum</subject><subject>Plasmodium falciparum - immunology</subject><subject>Protozoan Proteins - immunology</subject><subject>Pyrimethamine</subject><subject>Pyrimethamine - immunology</subject><subject>Pyrimethamine - therapeutic use</subject><subject>Seasons</subject><issn>0001-706X</issn><issn>1873-6254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUsuO1DAQjBBoGRb-ACSfEBwCduLEzgUJrXhJi-CwSNysjt2ZMfJjsJPVLp_IV-HMjPbIntxWVVe1uquqnjP6hlHWv6WUslrQ_uergb8eKBVNLR9UGyZFW_dNxx9WmzvK4-pJzr_KrxFdc1adCcloK9tN9fdqh8SGyS0YNJI4ka_g4j5ZT_QOfanifnfr4MZmEgPR6NziIBEIhuwWHxM4Yr1fApKEeR9DxkzmSL47yD4au3gygdN2D6mUkPFmKR2ji9GQPMMWi9JstxhymYJkvYvR6Z11JmEgzl7bsF0BIB6KrQWCwaC3mkBCOIwb_4Af7e8Fn1aPilXGZ6f3vPrx8cPVxef68tunLxfvL2vN2TDXXI5TK7teTEYOTddQBmCAj8Ckpj1DQaXpxMi70bR8QtlPUw_YdN0op14MbXtevTzqlt0U2zwrb_O6GAgYl6xEPzQNF-xeYtv0g2gYv5fIelFED9b8SNQp5pxwUuulIN0qRtUaCrVeXK0XVwNXh1AoWdpenPSX0aO5azqloODvjjiWtV1bTCpru-bB2IR6Viba_xv8A7eoy98</recordid><startdate>19940901</startdate><enddate>19940901</enddate><creator>Hogh, Birthe</creator><creator>Thompson, Ricardo</creator><creator>Lobo, Vitoria</creator><creator>Dgedge, Martinho</creator><creator>Dziegiel, Morten</creator><creator>Borre, Martin</creator><creator>Gottschau, Adam</creator><creator>Streat, Elisabeth</creator><creator>Schapira, Allan</creator><creator>Barreto, Jorge</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>M7N</scope><scope>7U5</scope><scope>8FD</scope><scope>L7M</scope><scope>7X8</scope></search><sort><creationdate>19940901</creationdate><title>The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique</title><author>Hogh, Birthe ; Thompson, Ricardo ; Lobo, Vitoria ; Dgedge, Martinho ; Dziegiel, Morten ; Borre, Martin ; Gottschau, Adam ; Streat, Elisabeth ; Schapira, Allan ; Barreto, Jorge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-48bf38567fd8925201aada4ba18c061e708d57b45bd34fe86ff6ae255b8f67933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Animals</topic><topic>Antibodies, Protozoan - biosynthesis</topic><topic>Antigens, Protozoan - immunology</topic><topic>Antimalarials - immunology</topic><topic>Antimalarials - therapeutic use</topic><topic>Cellular</topic><topic>Child</topic><topic>Cohort Studies</topic><topic>Cross-Sectional Studies</topic><topic>Dapsone</topic><topic>Dapsone - immunology</topic><topic>Dapsone - therapeutic use</topic><topic>Drug Combinations</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>GLURP</topic><topic>Humans</topic><topic>Humoral immune response</topic><topic>Immunity, Cellular - drug effects</topic><topic>Malaria, Falciparum - epidemiology</topic><topic>Malaria, Falciparum - immunology</topic><topic>Malaria, Falciparum - prevention &amp; control</topic><topic>Mozambique - epidemiology</topic><topic>Pf155/RESA</topic><topic>Plasmodium falciparum</topic><topic>Plasmodium falciparum - immunology</topic><topic>Protozoan Proteins - immunology</topic><topic>Pyrimethamine</topic><topic>Pyrimethamine - immunology</topic><topic>Pyrimethamine - therapeutic use</topic><topic>Seasons</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hogh, Birthe</creatorcontrib><creatorcontrib>Thompson, Ricardo</creatorcontrib><creatorcontrib>Lobo, Vitoria</creatorcontrib><creatorcontrib>Dgedge, Martinho</creatorcontrib><creatorcontrib>Dziegiel, Morten</creatorcontrib><creatorcontrib>Borre, Martin</creatorcontrib><creatorcontrib>Gottschau, Adam</creatorcontrib><creatorcontrib>Streat, Elisabeth</creatorcontrib><creatorcontrib>Schapira, Allan</creatorcontrib><creatorcontrib>Barreto, Jorge</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Technology Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>MEDLINE - Academic</collection><jtitle>Acta tropica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hogh, Birthe</au><au>Thompson, Ricardo</au><au>Lobo, Vitoria</au><au>Dgedge, Martinho</au><au>Dziegiel, Morten</au><au>Borre, Martin</au><au>Gottschau, Adam</au><au>Streat, Elisabeth</au><au>Schapira, Allan</au><au>Barreto, Jorge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique</atitle><jtitle>Acta tropica</jtitle><addtitle>Acta Trop</addtitle><date>1994-09-01</date><risdate>1994</risdate><volume>57</volume><issue>4</issue><spage>265</spage><epage>277</epage><pages>265-277</pages><issn>0001-706X</issn><eissn>1873-6254</eissn><abstract>We examined the impact of chemoprophylaxis on the cellular and humoral immune responses to polypeptides of the asexual Plasmodium falciparum blood stage antigens, the glutamate rich protein GLURP and Pf155/RESA, both of which in previous field studies have been identified as potentially protective antigens. The study was carried out in the Escola Primária de Lingamo, a primary school in a suburban area of Maputo, Mozambique. A cohort of 392 schoolchildren (aged 7–12 years) was randomly allocated to two equal groups, one receiving chemoprophylaxis with dapsone/pyrimethamine (Maloprim), the other receiving placebo every week from December 1989 to November 1990. The groups were then followed until November 1991 without chemoprophylaxis. Cellular responses to immunodominant epitopes from Pf155/RESA and GLURP, and to non malaria antigens C. albicans and PPD, were assessed by lymphocyte proliferation assays in vitro. Anti-GLURP and anti-Pf155/RESA antibodies were detected by enzyme-linked immunosorbent assay (ELISA) and erythrocyte membrane immunofluorescence (EMIF), and total anti- P. falciparum antibodies were measured by indirect fluorescent antibody test (IFAT). Immunological reactivities were evaluated every six months, at the end of the rainy season and at the end of the dry season, both during the period of chemoprophylaxis and during the follow-up. The antibody response rate to the GLURP was lower in the Maloprim group than in the placebo group during the intervention phase. The lymphoproliferative response rate to the malaria antigens was significantly lower at the end of the rainy season than at the end of the dry season, but the difference between the experimental group and the control group of schoolchildren was not statistically significant. These results suggest that the antibody responses to the GLURP molecule and partly to the Pf155/RESA antigen in this study population were shortlived and dependent on frequent boostering, but whether these antigens play a role in the development of natural clinical immunity remains open. In the experimental group of schoolchildren weekly chemoprophylaxis successfully reduced the parasite rate during the rainy season from 43% to 4%, and during the dry season from 18% to 0%. Chemoprophylaxis may therefore have a useful role in combination with another partially effective malaria control measure such as insecticide-impregnated bed nets or a malaria vaccine.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>7810383</pmid><doi>10.1016/0001-706X(94)90072-8</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-706X
ispartof Acta tropica, 1994-09, Vol.57 (4), p.265-277
issn 0001-706X
1873-6254
language eng
recordid cdi_proquest_miscellaneous_76922471
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antibodies, Protozoan - biosynthesis
Antigens, Protozoan - immunology
Antimalarials - immunology
Antimalarials - therapeutic use
Cellular
Child
Cohort Studies
Cross-Sectional Studies
Dapsone
Dapsone - immunology
Dapsone - therapeutic use
Drug Combinations
Enzyme-Linked Immunosorbent Assay
GLURP
Humans
Humoral immune response
Immunity, Cellular - drug effects
Malaria, Falciparum - epidemiology
Malaria, Falciparum - immunology
Malaria, Falciparum - prevention & control
Mozambique - epidemiology
Pf155/RESA
Plasmodium falciparum
Plasmodium falciparum - immunology
Protozoan Proteins - immunology
Pyrimethamine
Pyrimethamine - immunology
Pyrimethamine - therapeutic use
Seasons
title The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T04%3A44%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20influence%20of%20Maloprim%20chemoprophylaxis%20on%20cellular%20and%20humoral%20immune%20responses%20to%20Plasmodium%20falciparum%20asexual%20blood%20stage%20antigens%20in%20schoolchildren%20living%20in%20a%20malaria%20endemic%20area%20of%20Mozambique&rft.jtitle=Acta%20tropica&rft.au=Hogh,%20Birthe&rft.date=1994-09-01&rft.volume=57&rft.issue=4&rft.spage=265&rft.epage=277&rft.pages=265-277&rft.issn=0001-706X&rft.eissn=1873-6254&rft_id=info:doi/10.1016/0001-706X(94)90072-8&rft_dat=%3Cproquest_cross%3E76922471%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16776993&rft_id=info:pmid/7810383&rft_els_id=0001706X94900728&rfr_iscdi=true